The Michael and Dianne Bienes Comprehensive Cancer Center is committed to providing the absolute best care possible. One way we are doing this is by offering clinical trials for various cancers on a continuous basis. We are also now working together with Massachusetts General Hospital Cancer Center to provide South Florida residents with rapid access to specialized cancer care and genetic counseling.
Scroll through our current clinical trials below, or simply search for a specific trial by using the search field below.
-
BREAST
OAM4861g (MetMAB)
A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating The Safety and Efficacy of MetMAB in Combination With Paclitaxel and Bevacizumab in Patients With Metastatic, Trip-Negative Breast Cancer
-
BREAST
CALGB 40601
Randomized Phase III Trial of Paclitaxel Combined with Trastuzumab, Lapatinib, or Both As Neoadjuvant Treatment of HER2-Positive Primary Breast Cancer
-
BREAST
BRE 122
Phase I/II Trial of Neoadjuvant Sunitinib Administered with Weekly Paclitaxel/Carboplatin in Patients with Locally Advanced Triple-Negative Breast Cancer
-
BREAST
CTSU S1007
Endocrine Therapy +/- Chemo with 1-3 Positive Nodes, Hormone Receptor (+) and Her2 (-) with Recurrence Score (RS) of 25 or Less
-
BREAST
Registry
ASBrS Nipple Sparing Mastectomy Registry
-
BREAST
M12-895
A Randomized Phase 2 Study of the Efficacy and Tolerability of Veliparibin Combination with Temozolomide or Veliparib in Combination with Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Subjects with BRCA1 or BRCA2 Mutation and Metastatic Breast Cancer
-
BREAST
SWOG S0800
Phase II Randomized Study of Neoaduvant Paclitaxel Albumin-stabilized Nanoparticle Formulation, Doxorubicin Hydrochloride, Cyclophosphamide, and Pegfilgrastim with Versus Without Bevacizumab in Women with HER2/neu-Negative Inflammatory or Locally Advanced Breast Cancer
-
FOLLICULAR LYMPHOMA
RV-FOL-GELARC-0683C
A Phase 3 Open-Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects with Previously Untreated Follicular Lymphoma
-
GASTROINTESTINAL
CALGB 80405
A Phase III Trial Of Irinotecan / 5-Fu /Leucovorin Or Oxaliplatin / 5-Fu /Leucovorin With Bevacizumab, Or Cetuximab (C225), Or With The Combination Of Bevacizumab And Cetuximab For Patients With Untreated Metastatic Adenocarcinoma Of The Colon Or Rectum
-
Genetic Registry
City of Hope Registry
Molecular Genetics Studies of Cancer Patients and Their Relatives
-
GENITOURINARY
CTSU E3805
Chemo-Hormonal Therapy Versus Androgen Ablation Randomized Trial For Extensive Disease In Prostate Cancer
-
Leukemia
VOS-AML-301
A Phase III, Randomized, Controlled, Double Blind, Multinational cCinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients with First Relasped or Refractory Acute Myeloid Leukemia
-
LUNG
ECLIPSE
A Randomized Phase III Trial of Gemcitabine/Carboplatin With or Without BSI-201 (PARP Inhibitor) in Patients with Previously Untreated Stage IV Squamous Cell Non-Small Lung Cancer
-
LUNG
IMMUNO 007
A Phase 1/II Study to Assess the Safety, and Efficacy of Lorvotuzumab Mertansine (IMGN901) in Combination with Carboplatin/Etoposide in Patients with Advanced Solid Tumors Including Extensive Stage Small Cell Lung Cancer
-
NON-SMALL CELL LUNG CANCER
CTSU E1505
A Phase III Randomized Trial Of Adjuvant Chemotherapy With Or Without Bevacizumab For Patients With Completely Resected Stage Ib (> 4 Cm) – IIIa Non-Small Cell Lung Cancer (NSCLC)
-
NON-SMALL CELL LUNG CANCER
Pfizer A7471042
A Phase 2, Multi-Cohort Study to Evaluate the Impact of Prophylactic Intervention on Dermatologic and Gastrointestinal Adverse Events and Patient Reported Outcomes in Patients Treated with Dacomitinib (PF-00299804)
-
PROSTATE
TV-001-09
A Randomized Phase II Study to Assess the Activity of TroVax (MVA-5T4) Plus docetaxel Versus Docetaxel Alone in Subjects with Progressive Hormone Refractory Prostate Cancer
-
SMALL CELL LUNG CANCER
CALGB 30610
Phase III Comparison Of Thoracic Radiotherapy Regimens In Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin And Etoposide
-
SOLID TUMORS
TL32711-POC-0078-PTL
TetraLogic: A Phase IB/2A, Open-Label, Non-Randomized, Multi-Arm Study of TL32711 in Combination with Chemotherapy in Subjects with Advanced or Metastatic Solid Tumors
